NLC Pharma LTD

NLC Pharma is focusing on the development and commercialization of drugs and diagnostics that aim to stop the spread of diseases and can prevent them from becoming pandemics. The diagnostic division of NLC Pharma entered last April a collaboration agreement with Todos Medical for the development and commercialization of Saliva based rapid onsite detection method (10 min.) for COVID-19. NLC's Technology (Quantum Core Technology) is using unique method that creates potent inhibitors based on the virus target mechanism. Over 20 million dollars were invested over the past 20 years in the research and development of this technology. Based on this technology, the company has identified a potential proprietary formulation of high purity, better absorbed natural molecules, which are expected to eliminate the core reproduction mechanism of a viral family that included coronaviruses. The botanical material we use, Is a well-known material with comprehensive safety data that has been used in Chinese traditional medicine for years and is approved for use also by the Israeli Health ministry.